Condition: Insulinoma; Pancreas · Sponsor: Sahlgrenska University Hospital
Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies. In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.
This description comes directly from the study's public registry record.
Per Hedenström, Associate Professor · +46 31 3421000 · per.hedenstrom@vgregion.se
Riadh Sadik, Associate Professor · +46 31 3421000
Always discuss trial participation with your own doctor first.
| Sahlgrenska Univeristy Hospital | Gothenburg, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07585032